A randomized controlled trial of a novel AI-based prognostic decision support tool integrated into the electronic health record for ischemic heart disease: Rationale and design of the PM Heart trial
Publication date: Available online 18 October 2026 Source: American Heart Journal Author(s): Anna Kirstine Ringgaard, Søren Albertsen Rand, Chaoqun Zheng, Maria Elizabeth Engel Møller, Alex Hørby Christensen, Anders Christian Riis-Jensen, Bettina Wimmer, Dan Eik Høfsten, Johan Skov Bundgaard, Franziska Valder, Iben Mundbjerg Gjødsbøl, Mette Gørtz, Mette Hartlev, Mette Nordahl Svendsen, Sisse Rye Ostrowski, Erik Sørensen, Ole B Pedersen, Jonas Ghouse, Ida Gustafsson, Matias Greve Lindholm
A randomized controlled trial of a novel AI-based prognostic decision support tool integrated into the electronic health record for ischemic heart disease: Rationale and design of the PM Heart trial. // American Journal of Kidney Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S0002870326002930?dgcid=rss_sd_all
A randomized controlled trial of a novel AI-based prognostic decision support tool integrated into the electronic health record for ischemic heart disease: Rationale and design of the PM Heart trial. American Journal of Kidney Diseases. https://www.sciencedirect.com/science/article/pii/S0002870326002930?dgcid=rss_sd_all
“A randomized controlled trial of a novel AI-based prognostic decision support tool integrated into the electronic health record for ischemic heart disease: Rationale and design of the PM Heart trial.” American Journal of Kidney Diseases.
@article{article3310,
title = {A randomized controlled trial of a novel AI-based prognostic decision support tool integrated into the electronic health record for ischemic heart disease: Rationale and design of the PM Heart trial},
journal = {American Journal of Kidney Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S0002870326002930?dgcid=rss_sd_all}
}